Lamivudine and Adefovir to Treat Chronic Hepatitis B

This study is ongoing, but not recruiting participants.
Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			HBV
			Hepatitis B
			Hepatitis
			Liver
2		Additional conditions recognized in this trial
			Hepatitis B, Chronic
			Hepatitis, Chronic
3		More general conditions related to this trial
			Digestive System Diseases
			DNA Virus Infections
			Hepadnaviridae Infections
			Hepatitis, Viral, Human
			Liver Diseases
			Virus Diseases
4		Interventions listed in this trial
			Adefovir Dipivoxil
5		Additional drug interventions recognized in this trial
			Adefovir
			Lamivudine
6		More general drug interventions related to this trial
			Anti-HIV Agents
			Anti-Infective Agents
			Anti-Retroviral Agents
			Antiviral Agents
			Enzyme Inhibitors
			Molecular Mechanisms of Pharmacological Action
			Nucleic Acid Synthesis Inhibitors
			Pharmacologic Actions
			Reverse Transcriptase Inhibitors
			Therapeutic Uses
7		Sponsors listed in this trial
			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)